Abstract
Summaries for Patients2 July 2002Metformin for Patients with Type 2 Diabetes MellitusSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-137-1-200207020-00004 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Diabetes mellitus is a disease characterized by high levels of sugar (glucose) in the blood. Insulin (a chemical produced by the pancreas) helps regulate the level of glucose in the blood by facilitating its passage into the cells of the body, where it is used as a nutrient. When glucose enters cells, it is effectively removed from the blood and its concentration in the bloodstream decreases. Two types of diabetes mellitus are recognized. Type 1 (juvenile) diabetes is caused by a failure of the pancreas to produce insulin, ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Metformin: An Update.” It is in the 2 July 2002 issue of Annals of Internal Medicine (volume 137, pages 25-33). The authors are D Kirpichnikov, SI McFarlane, and JR Sowers.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoMetformin: An Update Dmitri Kirpichnikov , Samy I. McFarlane , and James R. Sowers Metrics Cited byPrognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes 2 July 2002Volume 137, Issue 1Page: I-50KeywordsBlood cellsBlood coagulationBlood sugarCellsDrugsGlucoseInsulin resistanceMetabolic syndromePancreasType 2 diabetes ePublished: 2 July 2002 Issue Published: 2 July 2002 Copyright & PermissionsCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
